On July 28, AMCP signed a Medicare Part D stakeholder letter urging HHS to extend the Enhanced Medication Therapy Management (EMTM) Model which is currently set to expire on December 31, 2021.
On July 26, AMCP joined other health care organizations in a joint statement in support of COVID-19 Vaccine mandates for all workers in health and long-term care.
AMCP submitted comments on a Office of Management and Budget request for information on advancing equity in underserved communities through government.
On June 14, AMCP submitted comments on the Medicare Part D Medication Therapy Management Program's Standardized Format for the comprehensive medication review.
On May 25, AMCP joined Medicare stakeholder organizations in thanking Congressional members for introducing the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 2759/S.1362).